PIM2
PIM2 is a proto-oncogene that encodes a serine/threonine kinase involved in cell survival and cell proliferation. Formerly known as the pim-2 oncogene, it belongs to the PIM kinase family and acts to prevent apoptosis. Browse Assay Genie's current range of PIM2 research reagents below, or read on for the biology behind the target.
PIM2 is a proto-oncogene with serine/threonine kinase activity that supports cell survival and cell proliferation. It exerts its oncogenic activity through several routes: regulation of MYC transcriptional activity, regulation of cell cycle progression, regulation of cap-dependent protein translation, and survival signalling through phosphorylation of the pro-apoptotic protein BAD. Phosphorylation of BAD induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Phosphorylation of MYC increases MYC protein stability and so its transcriptional activity, which may partly explain the strong synergism between these two oncogenes in tumorigenesis.
The PIM2 protein also regulates cap-dependent protein translation independently of mTORC1 and in parallel to the PI3K-Akt pathway. It promotes cell survival in response to a variety of proliferative signals through positive regulation of the I-kappa-B kinase/NF-kappa-B cascade, a process that requires phosphorylation of MAP3K8/COT. It drives growth factor-independent proliferation by phosphorylating cell cycle factors such as CDKN1A and CDKN1B, and it is involved in the positive regulation of chondrocyte survival and autophagy in the epiphyseal growth plate.
The PIM2 gene is catalogued by HGNC as the Pim-2 proto-oncogene, serine/threonine kinase, with the previous name pim-2 oncogene. The protein belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family, PIM subfamily, alongside PIM1 and PIM3. The mouse ortholog is Pim2. NCBI Gene summarises the encoded kinase as functioning to prevent apoptosis and promote cell survival.
PIM2 is a proto-oncogene whose kinase activity supports cell proliferation and survival, making it a focus for studies of oncogenic signalling.
PIM2 phosphorylates BAD, releasing Bcl-X(L)/BCL2L1, and so provides a route to study how survival signalling blocks apoptosis.
PIM2 stabilises MYC and phosphorylates CDKN1A and CDKN1B, linking it to transcriptional activity and growth factor-independent proliferation.
PIM2 regulates cap-dependent translation independently of mTORC1 and promotes the I-kappa-B kinase/NF-kappa-B cascade through MAP3K8/COT.
PIM2 is a serine/threonine kinase that promotes cell survival and proliferation. It phosphorylates MYC, BAD, CDKN1A, CDKN1B and MAP3K8/COT, and regulates cap-dependent translation independently of mTORC1. It also contributes to chondrocyte survival and autophagy in the epiphyseal growth plate.
HGNC lists the full name as Pim-2 proto-oncogene, serine/threonine kinase, and UniProt names the protein serine/threonine-protein kinase pim-2. The previous gene name was pim-2 oncogene. No alternative gene symbols are recorded in the source data.
PIM2 belongs to the PIM kinase family within the CAMK Ser/Thr protein kinase group, together with PIM1 and PIM3. A mouse ortholog, Pim2, exists; check the datasheet of any product for its validated reactivity.
Other members of the PIM kinase family with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9P1W9; product specifications from Assay Genie datasheets.